Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 29  •  04:00PM ET
73.71
Dollar change
-4.52
Percentage change
-5.78
%
Index
-
P/E
-
EPS (ttm)
-0.01
Insider Own
57.14%
Shs Outstand
41.25M
Perf Week
-15.12%
Market Cap
3.39B
Forward P/E
82.16
EPS next Y
0.90
Insider Trans
0.00%
Shs Float
19.70M
Perf Month
5.13%
Enterprise Value
3.00B
PEG
0.66
EPS next Q
0.03
Inst Own
14.37%
Perf Quarter
-14.34%
Income
-0.20M
P/S
11.11
EPS this Y
238.78%
Inst Trans
39.22%
Perf Half Y
-
Sales
305.11M
P/B
7.03
EPS next Y
89.16%
ROA
-0.04%
Perf YTD
-9.93%
Book/sh
10.48
P/C
6.84
EPS next 5Y
124.69%
ROE
-0.06%
52W High
138.70 -46.86%
Perf Year
-
Cash/sh
10.78
P/FCF
-
EPS past 3/5Y
- -
ROIC
-0.03%
52W Low
61.96 18.96%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
117.86
Sales past 3/5Y
106.24% -
Gross Margin
68.32%
Volatility
7.80% 8.61%
Perf 5Y
-
Dividend TTM
-
EV/Sales
9.84
EPS Y/Y TTM
99.30%
Oper. Margin
5.25%
ATR (14)
6.52
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
11.32
Sales Y/Y TTM
99.97%
Profit Margin
-0.06%
RSI (14)
41.81
Dividend Gr. 3/5Y
- -
Current Ratio
11.69
EPS Q/Q
121.55%
SMA20
-11.05%
Beta
-
Payout
0.00%
Debt/Eq
0.23
Sales Q/Q
113.09%
SMA50
-5.44%
Rel Volume
0.91
Prev Close
78.23
Employees
713
LT Debt/Eq
0.22
SMA200
-16.49%
Avg Volume
325.63K
Price
73.71
IPO
Nov 06, 2025
Option/Short
Yes / Yes
Trades
Volume
294,982
Change
-5.78%
Date Action Analyst Rating Change Price Target Change
Jan-06-26Initiated Guggenheim Buy $120
Dec-01-25Initiated William Blair Outperform
Dec-01-25Initiated Wells Fargo Equal Weight $110
Dec-01-25Initiated Stifel Buy $145
Dec-01-25Initiated Piper Sandler Overweight $150
Dec-01-25Initiated JP Morgan Overweight $150
Dec-01-25Initiated Jefferies Hold $117
Dec-01-25Initiated BTIG Research Buy $160
Apr-15-26 08:05AM
Apr-02-26 09:00AM
Mar-06-26 07:03AM
Mar-05-26 12:01AM
Mar-04-26 07:00PM
06:00PM Loading…
06:00PM
04:38PM
04:05PM
Feb-27-26 03:40AM
Feb-17-26 08:05AM
Feb-10-26 09:00AM
Feb-09-26 12:29PM
Jan-23-26 10:23AM
Jan-15-26 08:58AM
Jan-13-26 09:43AM
04:24AM Loading…
04:24AM
Jan-12-26 08:05AM
Jan-06-26 09:00AM
Jan-01-26 12:13AM
Dec-23-25 08:05AM
Dec-09-25 04:07PM
04:05PM
07:10AM
Dec-03-25 04:00PM
Dec-02-25 08:05AM
Dec-01-25 12:16PM
09:46AM
Nov-26-25 12:59PM
Nov-25-25 05:00PM
Nov-18-25 12:34AM
04:05PM Loading…
Nov-07-25 04:05PM
Nov-06-25 05:02PM
03:39PM
Nov-05-25 09:53PM
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. BillionToOne was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.